CONDENSED CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 30, 2021	Dec. 31, 2020
Current assets:
Cash and cash equivalents	$ 95,161	$ 78,708
Research and development incentive receivable	1,053	917
Prepaid expenses and other current assets	5,157	3,682
Total current assets	101,371	83,307
Property and equipment, net	1,745	1,237
Goodwill	27,109	27,109
Right-of-use assets	9,430	7,960
Other assets	2,004	3,258
Total assets	141,659	122,871
Current liabilities:
Accounts payable	2,528	3,144
Accrued expenses	9,607	8,018
Current portion of lease liability	985	786
Total current liabilities	13,120	11,948
Long-term debt, including accretion, net of discount	33,542	33,178
Lease liabilities	5,350	4,484
Other liabilities	434	462
Total liabilities	52,446	50,072
Commitments and contingencies (Note 9)
Redeemable common stock, 229,885 and zero issued and outstanding at June 30, 2021 and December 31, 2020, respectively (Note 11)	1,875	0
Stockholders’ equity:
Common stock, $0.001 par value, 125,000,000 shares authorized as of each of June 30, 2021 and December 31, 2020; 24,584,858 and 16,305,731 shares issued and outstanding as of June 30, 2021 and December 31, 2020, respectively	25	16
Additional paid-in capital	319,921	267,077
Accumulated other comprehensive loss	(119)	(119)
Accumulated deficit	(232,489)	(194,175)
Total stockholders’ equity	87,338	72,799
Total liabilities, redeemable common stock and stockholders’ equity	$ 141,659	$ 122,871